FLARE THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 28 Oct 2025)
What this means for you
Not registered yet, but its 20 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98610753
- Mark type
- Stylized text
- Filed
- 20 Jun 2024
- Published for opposition
- 04 Mar 2025
- Attorney of record
- Shane Rumbaugh
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of biochemical systems, namely, custom manufacture of systems for targeting transcription factors; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders
Owner
- Flare Therapeutics Inc., Cambridge, MA, US
- Flare Therapeutics Inc., Cambridge, MA, US
Prosecution history
- 29 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Oct 2025 — SOU EXTENSION 1 GRANTED
- 28 Oct 2025 — SOU EXTENSION 1 FILED
- 28 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Mar 2025 — PUBLISHED FOR OPPOSITION
- 04 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED